Duff & Phelps Healthcare and Life Sciences team provides Fortune 500 corporations, middle-market and growth companies and financial sponsors access to our valuation and corporate finance services.
Our dedicated team completes nearly 200 healthcare engagements annually, including engagements in healthcare services, Pharmaceuticals, Medical Technology and Life Sciences. As a firm, Duff & Phelps stands alone in our objectivity, deep technical and industry expertise and breadth of advisory services.
Comprehensive support throughout mergers and acquisitions and other corporate transactions.
Fairness and Solvency Opinions
Independent opinions for boards of directors and special committees.
Private Capital Markets – Debt Advisory
Advice on capital raising and securing best market terms across the capital structure from senior debt to equity.
Transaction Advisory Services
Seamless analytical advisory through the deal continuum, from transaction origination to closing.
Financial Sponsors Group
Dedicated coverage and access to M&A deal-flow for financial sponsors.
Governance, Risk, Investigations and Disputes
Combined Duff & Phelps and Kroll disputes, investigations, cyber, business intelligence, restructuring and other advisory.
Valuation and consulting for financial reporting, federal, state and local tax, investment and risk management purposes.
a portfolio company of
has been acquired by
has entered into an agreement to sell its Life Sciences division to
Duff & Phelps Advised Cristian Lay on its acquisition of Grupo Gallardo to KKR on the standstill agreement between all lenders, assist with cash management, financial due diligence and operational due diligence.
has completed a debt for equity exchange as part of a restructuring transaction
Keeping It Real…Or Personal: With Property, What’s the Difference?
COVID-19 Impact on Commercial Property Taxes – The Bad, the Good and the Ugly
Is Recovery in Sight?
The World in Deep Recession
Expect the Sale-and-Leaseback Flurry to Quicken
Plenty of Life Left in City Offices
Work Will Change, but the Office Is Here to Stay
Ross Prindle Discusses Property Valuations Amid the Coronavirus with GlobeSt.com
Ross Prindle Quoted in S&P Global Market Intelligence Discussing Retail Real Estate
James Liddiment Speaks to Estates Gazette About the Impact of COVID-19 on the Real Estate Industry
Ross Prindle Discusses COVID-19 Impact on Senior Living with Bisnow
Ross Prindle discusses COVID-19 Impacts on Real Estate Financing With Law360
COVID-19 Escalation Renders GP Reporting ‘Out of Date Almost Immediately'
David Larsen Discusses How to Value LP Stakes in Light of COVID-19